Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, TreatmentsInvestorPlace • 05/20/22
Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2GlobeNewsWire • 05/18/22
Tonix Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational HighlightsGlobeNewsWire • 05/09/22
Tonix Pharmaceuticals to Present at B. Riley Securities' 2022 Virtual Neuro & Ophthalmology ConferenceGlobeNewsWire • 04/25/22
Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID PatientsGlobeNewsWire • 04/20/22
Tonix Pharmaceuticals Announces IND Clearance for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19 (PASC)GlobeNewsWire • 04/06/22